These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 35831273)

  • 1. Aurora-A/FOXO3A/SKP2 axis promotes tumor progression in clear cell renal cell carcinoma and dual-targeting Aurora-A/SKP2 shows synthetic lethality.
    Li P; Chen T; Kuang P; Liu F; Li Z; Liu F; Wang Y; Zhang W; Cai X
    Cell Death Dis; 2022 Jul; 13(7):606. PubMed ID: 35831273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aurora-A/ERK1/2/mTOR axis promotes tumor progression in triple-negative breast cancer and dual-targeting Aurora-A/mTOR shows synthetic lethality.
    Zhang W; Xia D; Li Z; Zhou T; Chen T; Wu Z; Zhou W; Li Z; Li L; Xu J
    Cell Death Dis; 2019 Aug; 10(8):606. PubMed ID: 31406104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nobiletin downregulates the SKP2-p21/p27-CDK2 axis to inhibit tumor progression and shows synergistic effects with palbociclib on renal cell carcinoma.
    Chen T; Liu L; Zou Y; Hu X; Zhang W; Zhou T; Luo X; Fu W; Xu J
    Cancer Biol Med; 2021 Feb; 18(1):227-244. PubMed ID: 33628597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of Akt/FoxO3a/Skp2 Axis Is Critically Involved in Berberine-Induced Cell Cycle Arrest in Hepatocellular Carcinoma Cells.
    Li F; Dong X; Lin P; Jiang J
    Int J Mol Sci; 2018 Jan; 19(2):. PubMed ID: 29360760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VHL loss predicts response to Aurora kinase A inhibitor in renal cell carcinoma cells.
    Ding XF; Zhou J; Chen G; Wu YL
    Mol Med Rep; 2018 Jul; 18(1):1206-1210. PubMed ID: 29845253
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EMX2 inhibits clear cell renal cell carcinoma progress via modulating Akt/FOXO3a pathway.
    Zhou X; Dong S; Zhou Y; He Z; Zhang Z; Liao L; Zou B; Zheng X; Peng K; Duan X
    Mol Carcinog; 2024 May; 63(5):951-961. PubMed ID: 38362840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of FOXO3a promotes tumor metastasis and is associated with metastasis-free survival of patients with clear cell renal cell carcinoma.
    Ni D; Ma X; Li HZ; Gao Y; Li XT; Zhang Y; Ai Q; Zhang P; Song EL; Huang QB; Fan Y; Zhang X
    Clin Cancer Res; 2014 Apr; 20(7):1779-90. PubMed ID: 24486593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of pVHL as a novel substrate for Aurora-A in clear cell renal cell carcinoma (ccRCC).
    Martin B; Chesnel F; Delcros JG; Jouan F; Couturier A; Dugay F; Le Goff X; Patard JJ; Fergelot P; Vigneau C; Rioux-Leclerq N; Arlot-Bonnemains Y
    PLoS One; 2013; 8(6):e67071. PubMed ID: 23785518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GYS1 induces glycogen accumulation and promotes tumor progression via the NF-κB pathway in Clear Cell Renal Carcinoma.
    Chen SL; Huang QS; Huang YH; Yang X; Yang MM; He YF; Cao Y; Guan XY; Yun JP
    Theranostics; 2020; 10(20):9186-9199. PubMed ID: 32802186
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FOXO3a reactivation mediates the synergistic cytotoxic effects of rapamycin and cisplatin in oral squamous cell carcinoma cells.
    Fang L; Wang H; Zhou L; Yu D
    Toxicol Appl Pharmacol; 2011 Feb; 251(1):8-15. PubMed ID: 21092744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The expression and prognosis of FOXO3a and Skp2 in human hepatocellular carcinoma.
    Lu M; Ma J; Xue W; Cheng C; Wang Y; Zhao Y; Ke Q; Liu H; Liu Y; Li P; Cui X; He S; Shen A
    Pathol Oncol Res; 2009 Dec; 15(4):679-87. PubMed ID: 19404778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A positive feed-forward loop between LncRNA-URRCC and EGFL7/P-AKT/FOXO3 signaling promotes proliferation and metastasis of clear cell renal cell carcinoma.
    Zhai W; Zhu R; Ma J; Gong D; Zhang H; Zhang J; Chen Y; Huang Y; Zheng J; Xue W
    Mol Cancer; 2019 Apr; 18(1):81. PubMed ID: 30953521
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting Aurora A kinase activity with the investigational agent alisertib increases the efficacy of cytarabine through a FOXO-dependent mechanism.
    Kelly KR; Nawrocki ST; Espitia CM; Zhang M; Yang JJ; Padmanabhan S; Ecsedy J; Giles FJ; Carew JS
    Int J Cancer; 2012 Dec; 131(11):2693-703. PubMed ID: 22488249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aurora kinase a inhibitor MLN8237 suppresses pancreatic cancer growth.
    Zhang Y; Ma Y; Wang Y; Mukhopadhyay D; Bi Y; Ji B
    Pancreatology; 2022 Jun; 22(5):619-625. PubMed ID: 35550115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AURKB/CDC37 complex promotes clear cell renal cell carcinoma progression via phosphorylating MYC and constituting an AURKB/E2F1-positive feedforward loop.
    Li F; Wang X; Zhang J; Jing X; Zhou J; Jiang Q; Cao L; Cai S; Miao J; Tong D; Shyy JY; Huang C
    Cell Death Dis; 2024 Jun; 15(6):427. PubMed ID: 38890303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VHL mutation-mediated SALL4 overexpression promotes tumorigenesis and vascularization of clear cell renal cell carcinoma via Akt/GSK-3β signaling.
    Sun J; Tang Q; Gao Y; Zhang W; Zhao Z; Yang F; Hu X; Zhang D; Wang Y; Zhang H; Song B; Zhang B; Wang H
    J Exp Clin Cancer Res; 2020 Jun; 39(1):104. PubMed ID: 32513235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imbalance between MMP-2, 9 and TIMP-1 promote the invasion and metastasis of renal cell carcinoma via SKP2 signaling pathways.
    Lu H; Cao X; Zhang H; Sun G; Fan G; Chen L; Wang S
    Tumour Biol; 2014 Oct; 35(10):9807-13. PubMed ID: 24986570
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocking the autocrine regulatory loop of Gankyrin/STAT3/CCL24/CCR3 impairs the progression and pazopanib resistance of clear cell renal cell carcinoma.
    Wang C; Wang Y; Hong T; Cheng B; Gan S; Chen L; Zhang J; Zuo L; Li J; Cui X
    Cell Death Dis; 2020 Feb; 11(2):117. PubMed ID: 32051393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alisertib, an Aurora kinase A inhibitor, induces apoptosis and autophagy but inhibits epithelial to mesenchymal transition in human epithelial ovarian cancer cells.
    Ding YH; Zhou ZW; Ha CF; Zhang XY; Pan ST; He ZX; Edelman JL; Wang D; Yang YX; Zhang X; Duan W; Yang T; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():425-64. PubMed ID: 25624750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.